Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank23
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P23
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -17.08% |
| Q3 2025 | -5.39% |
| Q2 2025 | -29.86% |
| Q1 2025 | 56.22% |
| Q4 2024 | -20.49% |
| Q3 2024 | -0.72% |
| Q2 2024 | 1.13% |
| Q1 2024 | 34.13% |
| Q4 2023 | -13.82% |
| Q3 2023 | -14.27% |
| Q2 2023 | 20.99% |
| Q1 2023 | 44.18% |
| Q4 2022 | 40.95% |
| Q3 2022 | -14.33% |
| Q2 2022 | -0.76% |
| Q1 2022 | 6.63% |
| Q4 2021 | -31.68% |
| Q3 2021 | 47.62% |
| Q2 2021 | 16.02% |
| Q1 2021 | 89.30% |
| Q4 2020 | -46.02% |
| Q3 2020 | 70.63% |
| Q2 2020 | -11.91% |
| Q1 2020 | -2.31% |
| Q4 2019 | -26.00% |
| Q3 2019 | -2.43% |
| Q2 2019 | 29.00% |
| Q1 2019 | 33.61% |
| Q4 2018 | -39.10% |
| Q3 2018 | 38.22% |
| Q2 2018 | -27.15% |
| Q1 2018 | 44.25% |
| Q4 2017 | -13.68% |
| Q3 2017 | -18.61% |
| Q2 2017 | 11.65% |
| Q1 2017 | 62.06% |
| Q4 2016 | -7.46% |
| Q3 2016 | 1.70% |
| Q2 2016 | -33.27% |
| Q1 2016 | 269.77% |